Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Cells|June 21, 2020
Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse ImagingHsiao-Chuan Liu, Eun Ji Gang, Hye Na Kim, et al.Current Cancer Drug Targets|December 17, 2010
The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cellsYong-Mi Kim, Hong Ma, Vivian G Oehler, et al.Blood|September 27, 2003
Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioningYong-Mi Kim, Markus Y Mapara, Julian D Down, et al.Frontiers in Cell and Developmental Biology|April 21, 2023
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemiaHeather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, et al.Scientific Reports|October 26, 2018
Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic TweezersHsiao-Chuan Liu, Eun Ji Gang, Hye Na Kim, et al.Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.International Journal of Molecular Sciences|February 9, 2020
Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaAaron Kruse, Nour Abdel-Azim, Hye Na Kim, et al.Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemiaCoralie Poulard, Hye Na Kim, Mimi Fang, et al.The Korean Journal of Internal Medicine|March 28, 2016
Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in KoreaIn Ah Choi, Jin-Hee Kim, Yong Mi Kim, et al.Biorxiv : the Preprint Server for Biology|January 23, 2026
Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerHyung-Gyoo Kang, Bryon Upton, Ryan W Holly, et al.Pageof 8